Cite
HARVARD Citation
Chung, H. et al. (2018). Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer. Asia-Pacific journal of clinical oncology. 14 (3), pp. 204-209. [Online].